The pharmacokinetics of enrofloxacin (EFX) and ciprofloxacin (CFX) was investigated in broiler chickens. Each antimicrobial was administered intravenously at a dose of 5 mg/kg body weight. Blood was taken in different preset times: prior and at 0.03, 0.06, 0.13, 0.25, 0.5, 1, 2, 4, 8, 12 and 24 h following drug administration. The concentrations of EFX and CFX in plasma were determined by high pressure liquid chromatography (HPLC). Plasma concentrations vs. time were analysed by a compartmental independent pharmacokinetic model that provided the most important kinetic parameters. Statistically significant differences between the two antimicrobials were found for most of the pharmacokinetic parameters: Area under the curve (AUC), area under first moment curve (AUMC), mean residence time (MRT), total body cleareance (ClB), volume of distribution beta (Vd beta) and volume of distribution at the steady state (Vd(ss)). Both antimicrobials were widely distributed in chickens throughout the body with a mean Vd(ss) of 1.98+/-0.18 L/kg for EFX, and 4.04+/-0.69 L/kg for CFX. The ClB for CFX was five times higher than that obtained for EFX. AUC, MRT and the diminished half time for EFX were two-four times higher than those obtained for CFX. These results indicate that CFX remains in the body for less time than the other quinolone. This characteristic of CFX suggests the advantage of a shorter withdrawal time for food producing animals treated with this antimicrobial.

Tabla S1. Concentration of enrofloxacin (n = 5, The mean ± SD) in plasma and tissues of group A trout (single dose of 10 mg/kg orally) Time (hours) Plasma Skin Muscle Liver Kidney Gut 0.25 0.

No abstract

No abstract

El estudio tuvo como objetivo evaluar la respuesta del eugenol, propofol, isofluorano y lidocaína sobre variables fisiológicas y anestesiológicas de Cheirodon interruptus, el pez cebo de mayor utilización en Argentina. Se conformaron seis grupos: eugenol 25 mg/l, eugenol 50 mg/l, lidocaína 300 mg/l, isofluorano 0.2 mg/l, isofluorano 0.4 mg/l y propofol 5 mg/l. Los ensayos se realizaron con agua a temperatura de 18.03±2.1 °C, pH 6.87±0.18, oxígeno disuelto 6.73±0.05 mg l-1 y conductividad 3.74±0.04 μS cm-. El peso (1.6±0.4 g) y longitud total (5.1±0.4 cm) inicial fueron estadísticamente similares entre grupos. Los resultados indican que eugenol e isofluorano se ajustan a los requerimientos que debe reunir un buen anestésico para uso en peces. Para propofol y lidocaína se considera necesario revisar la dosificación para adecuar su uso en C. interruptus debido al elevado tiempo de recuperación. Los peces tratados con isoflurano (0.4 mg/l) y propofol tuvieron una disminución significativa (p<0.001 y p<0.05, respectivamente) entre la frecuencia respiratoria basal y durante la anestesia. Ninguno de los fármacos utilizados provocó muertes de peces.